Ann: Shareholder Briefings, page-35

The valuation imo isn't going to change much until we get another announcement. The traded daily volume is currently at about .002% of shares on issue and the sell side is very weak. 1.6 has been washed enough now it seems and highly likely 1.7 will be the new base. At least they are showing signs of taking the company to the next level and the Genentech announcement may be the catalyst for some real Growth. End game here isn't the current sp, it's the valuation at the time of any buyout that may occur should the results be as promising as they think they are. Hopefully the briefings bring in some new large punters as I would think long term holders most probably have enough after the cap raising.
It seems no one wants any piece of the pycoa'a on offer but they might get a run if the next announcement is really good.